Klein Lawrence Otto sold ORKA
November 2, 2026 · Form 4 insider transaction
Klein Lawrence Otto sold 756 shares of Oruka Therapeutics, Inc. at $97.45 per share, a transaction worth $73.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
756
Price
$97.45
Total value
$73.7K
InsiderKlein Lawrence Otto
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 2, 2026
Filing dateNovember 2, 2026
Shares owned after923,428
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on May 14, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.30 to $98.12, inclusive.